Rachid Hocine

U830, 26, Rue D'Ulm
Paris, 75005, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Irreversible Electroporation Enhances Solid Tumor Infiltration and Selective Cancer Cell Lysis by CAR T Cells.

Irreversible Electroporation Enhances Solid Tumor Infiltration and Selective Cancer Cell Lysis by CAR T Cells.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 31, 2025

Irreversible Electroporation Enhances Solid Tumor Infiltration and Selective Cancer Cell Lysis by CAR T Cells.

Irreversible Electroporation Enhances Solid Tumor Infiltration and Selective Cancer Cell Lysis by CAR T Cells.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 31, 2025

IL7-Receptor-Targeted CAR T-Cell Therapy for T-Cell Acute Lymphoblastic Leukemia.

IL7-Receptor-Targeted CAR T-Cell Therapy for T-Cell Acute Lymphoblastic Leukemia.

Journal: Nature communications

Published: August 20, 2025

Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway.

Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway.

Journal: Nature communications

Published: March 06, 2023

Imaging CAR T-cell kinetics in solid tumors: Translational implications.

Imaging CAR T-cell kinetics in solid tumors: Translational implications.

Journal: Molecular therapy oncolytics

Published: November 11, 2020

Commentary: Long-term in vivo microscopy of CAR T cell dynamics during eradication of CNS lymphoma in mice.

Commentary: Long-term in vivo microscopy of CAR T cell dynamics during eradication of CNS lymphoma in mice.

Journal: Frontiers in immunology

Published: April 13, 2020

Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in Cancer.

Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in Cancer.

Journal: Cancer discovery

Published: November 26, 2019

Extracellular Vesicles Released by Allogeneic Human Cardiac Stem/Progenitor Cells as Part of Their Therapeutic Benefit.

Extracellular Vesicles Released by Allogeneic Human Cardiac Stem/Progenitor Cells as Part of Their Therapeutic Benefit.

Journal: Stem cells translational medicine

Published: November 06, 2018

Corrigendum: Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells.

Corrigendum: Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells.

Journal: Scientific reports

Published: October 21, 2017

Human Cardiac-Derived Stem/Progenitor Cells Fine-Tune Monocyte-Derived Descendants Activities toward Cardiac Repair.

Human Cardiac-Derived Stem/Progenitor Cells Fine-Tune Monocyte-Derived Descendants Activities toward Cardiac Repair.

Journal: Frontiers in immunology

Published: August 02, 2017

Corrigendum: Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells.

Corrigendum: Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells.

Journal: Scientific reports

Published: March 17, 2017

Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells.

Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells.

Journal: Scientific reports

Published: July 13, 2016

Showing 1-12 of 12

Last Updated: 09/26/2026